These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21727663)

  • 1. Quality of life after electroconvulsive therapy in persons with treatment resistant schizophrenia.
    Garg R; Chavan BS; Arun P
    Indian J Med Res; 2011 Jun; 133(6):641-4. PubMed ID: 21727663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
    Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
    Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia.
    Melzer-Ribeiro DL; Napolitano IC; Leite SA; Alencar de Souza JA; Vizzotto ADB; Di Sarno ES; Fortes M; Gomes ML; de Oliveira GM; Avrichir BS; Talib LL; Correll CU; Elkis H
    Schizophr Res; 2024 Jun; 268():252-260. PubMed ID: 38151432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of antipsychotics with electroconvulsive therapy in treatment-resistant schizophrenia patients with dominant negative symptoms: a pilot study of effectiveness.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Neuropsychobiology; 2014; 70(3):158-64. PubMed ID: 25358377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Psychiatry Res; 2014 Dec; 220(1-2):175-80. PubMed ID: 25129562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine.
    Youn T; Jeong SH; Kim YS; Chung IW
    Psychiatry Res; 2019 Mar; 273():759-766. PubMed ID: 31207863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK; Ungvari GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor serum levels in treatment-resistant schizophrenic patients following electroconvulsive therapy.
    Pacitti F; Bersani G; Aloe L; Caredda M; Orsi P; Quartini A; Vitali M; Ceccanti M; Tirassa P; Fiore M; Iannitelli A
    Clin Ter; 2021; 171(1):e67-e74. PubMed ID: 33346332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of electroconvulsive therapy combined with different antipsychotic drugs in previously resistant schizophrenia.
    Ravanić DB; Pantović MM; Milovanović DR; Dukić-Dejanović S; Janjić V; Ignjatović DR; Jović SD; Jurisić V; Jevtović I
    Psychiatr Danub; 2009 Jun; 21(2):179-86. PubMed ID: 19556946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Electroconvulsive Therapy Augmentation of Antipsychotic Treatment on Cognitive Functions in Patients With Treatment-Resistant Schizophrenia.
    Vuksan Ćusa B; Klepac N; Jakšić N; Bradaš Z; Božičević M; Palac N; Šagud M
    J ECT; 2018 Mar; 34(1):31-34. PubMed ID: 29053485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT).
    Shahin O; Gohar SM; Ibrahim W; El-Makawi SM; Fakher W; Taher DB; Abdel Samie M; Khalil MA; Saleh AA
    Int J Psychiatry Clin Pract; 2022 Nov; 26(4):370-375. PubMed ID: 35192426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation Electroconvulsive Therapy for Patients With Clozapine-Resistant Schizophrenia: A Pilot Study.
    Braga RJ; John M; Schooler NR; Bailine SH; Malur C; Mendelowitz A; Petrides G
    J ECT; 2019 Sep; 35(3):156-160. PubMed ID: 30973454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness and speed of response of electroconvulsive therapy in treatment-resistant schizophrenia.
    Chan CYW; Abdin E; Seow E; Subramaniam M; Liu J; Peh CX; Tor PC
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):416-422. PubMed ID: 31026106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECT augmentation of antipsychotics in severely ill schizophrenia: a naturalistic, observational study.
    Usta Saglam NG; Aksoy Poyraz C; Yalcin M; Balcioglu I
    Int J Psychiatry Clin Pract; 2020 Nov; 24(4):392-397. PubMed ID: 32538214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Electroconvulsive Therapy and Associated Cognitive Change in Schizophrenia: A Naturalistic, Comparative Study of Treating Schizophrenia With Electroconvulsive Therapy.
    Tor PC; Ying J; Ho NF; Wang M; Martin D; Ang CP; Tan C; Yap LS; Lu VJM; Simpson B; Mok YM; Loo C
    J ECT; 2017 Dec; 33(4):272-277. PubMed ID: 28640170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of clozapine with ECT: a retrospective case analysis.
    Lally J; Breese E; Osman M; Hua Sim C; Shetty H; Krivoy A; MacCabe JH
    Acta Neuropsychiatr; 2021 Feb; 33(1):31-36. PubMed ID: 32967745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).
    Moulier V; Krir MW; Dalmont M; ; Guillin O; Rothärmel M
    Trials; 2021 Apr; 22(1):284. PubMed ID: 33858488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness of electroconvulsive therapy in adolescents with schizophrenia spectrum disorders.
    Flamarique I; Baeza I; de la Serna E; Pons A; Bernardo M; Castro-Fornieles J
    Eur Child Adolesc Psychiatry; 2015 May; 24(5):517-24. PubMed ID: 25183368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECT-induced brain plasticity correlates with positive symptom improvement in schizophrenia by voxel-based morphometry analysis of grey matter.
    Wang J; Tang Y; Curtin A; Xia M; Tang X; Zhao Y; Li Y; Qian Z; Sheng J; Zhang T; Jia Y; Li C; Wang J
    Brain Stimul; 2019; 12(2):319-328. PubMed ID: 30473477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Electroconvulsive Therapy on Some Inflammatory Factors in Patients With Treatment-Resistant Schizophrenia.
    Kartalci S; Karabulut AB; Erbay LG; Acar C
    J ECT; 2016 Sep; 32(3):174-9. PubMed ID: 26886746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.